abstract
Expanded tandem repeat sequences in DNA are associated with at least 40
human genetic neurological, neurodegenerative, and neuromuscular
diseases. Repeat expansion can occur during parent-to-offspring
transmission, and arise at variable rates in specific tissues throughout
the life of an affected individual. Since the ongoing somatic repeat
expansions can affect disease age-of-onset, severity, and progression,
targeting somatic expansion holds potential as a therapeutic target.
Thus, understanding the factors that regulate this mutation is crucial.
DNA repair, in particular mismatch repair (MMR), is the major driving
force of disease-associated repeat expansions. In contrast to its
anti-mutagenic roles, mammalian MMR curiously drives the expansion
mutations of disease-associated (CAG)•(CTG) repeats. Recent advances
have broadened our knowledge of both the MMR proteins involved in
disease repeat expansions, including: MSH2,
MSH3, MSH6, MLH1, PMS2, and MLH3, as well as the types of repeats
affected by MMR, now including: (CAG)·(CTG), (CGG)·(CCG), and
(GAA)·(TTC) repeats. Mutagenic slipped-DNA structures have been detected
in patient tissues, and the size of the slip-out and their junction
conformation can determine the involvement of MMR. Furthermore, the
formation of other unusual DNA and R-loop structures is proposed to play
a key role in MMR-mediated instability. A complex correlation is
emerging between tissues showing varying amounts of repeat instability
and MMR expression levels. Notably, naturally occurring polymorphic
variants of DNA repair genes can have dramatic effects upon the levels
of repeat instability, which may explain the variation in disease
age-of-onset, progression and severity. An increasing grasp of these
factors holds prognostic and therapeutic potential.
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.